Pioneers in the development of bacterial spores as heat stable mucosal vaccines. Oral and sub-lingual delivery.
Expertise in Bacillus probiotics. Development and licensing of novel Bacillus carotenoid rich strains.
Development of Bacillus spores for directed targeting of cancerous cells with anti-tumour drugs
Strain constructions, genetic engineering of Bacillus, QPS and GRAS safety assessments, and more